Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Review

The safety profile of drotrecogin alfa (activated)

Roberto Fumagalli* and Mariano A Mignini

Critical Care 2007, 11(Suppl 5):S6 doi:10.1186/cc6157

No comments have yet been made on this article.

Post a comment